Raúl T.
- Country
- Spain
- Department
- Medical Oncology
Research Overview
- Phase I/II Randomized Study of LB-100 and Doxorubicin Versus Doxorubicin Monotherapy in Advanced Soft Tissue Sarcomas
- A Phase 3 Multicenter Randomized Study Comparing INT230-6 (Vinblastine Sulfate, Cisplatin) to Standard Care in Adults with Metastatic Soft Tissue Sarcomas
- Randomized Controlled Trial of Chemotherapy Regimens Including Gemcitabine, Lenvatinib, and Temozolomide for Recurrent and Primary Refractory Ewing Sarcoma
Data & Insights
Has run more than one trial at 12 of 69 partner sites.
Specializations
Sarcoma Treatment
The investigator specializes in treating various forms of soft tissue sarcomas, with particular focus on Ewing sarcoma and advanced cases including refractory conditions.
- Undifferentiated Pleomorphic Sarcoma
- Leiomyosarcoma
- Liposarcoma Variants
Research extends to novel therapeutic approaches for treating advanced and metastatic sarcomas.
Gastrointestinal Oncology
Focused on advancing treatments for gastric and gastroesophageal junction cancers, including resectable disease management and gastrointestinal stromal tumors (GIST).
- Gastric Adenocarcinoma
- Gastroesophageal Junction Cancer
- KIT-mutated GIST
Expertise includes neoadjuvant and adjuvant treatment approaches for gastrointestinal malignancies.
Rare Tumors
Specialized in treating tenosynovial giant cell tumors through innovative therapeutic approaches and clinical investigations.
- Novel Targeted Therapies
- Immunotherapy Applications
- Response Assessment Methods
Dedicated to developing treatment strategies for rare tumor types using emerging therapeutic agents.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.